- Home
- MCHX vs MNOV Comparison
MCHX vs MNOV Comparison
Compare MCHX & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCHX
- MNOV
- Stock Information
- Founded
- MCHX 2003
- MNOV 2000
- Country
- MCHX United States
- MNOV United States
- Employees
- MCHX N/A
- MNOV N/A
- Industry
- MCHX Business Services
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- MCHX Consumer Discretionary
- MNOV Health Care
- Exchange
- MCHX Nasdaq
- MNOV Nasdaq
- Market Cap
- MCHX 79.9M
- MNOV 87.3M
- IPO Year
- MCHX 2004
- MNOV 2005
- Fundamental
- Price
- MCHX $1.70
- MNOV $1.83
- Analyst Decision
- MCHX
- MNOV
- Analyst Count
- MCHX 0
- MNOV 0
- Target Price
- MCHX N/A
- MNOV N/A
- AVG Volume (30 Days)
- MCHX 33.5K
- MNOV 136.9K
- Earning Date
- MCHX 10-31-2024
- MNOV 11-13-2024
- Dividend Yield
- MCHX N/A
- MNOV N/A
- EPS Growth
- MCHX N/A
- MNOV N/A
- EPS
- MCHX N/A
- MNOV N/A
- Revenue
- MCHX $48,594,000.00
- MNOV N/A
- Revenue This Year
- MCHX N/A
- MNOV N/A
- Revenue Next Year
- MCHX $4.20
- MNOV N/A
- P/E Ratio
- MCHX N/A
- MNOV N/A
- Revenue Growth
- MCHX N/A
- MNOV N/A
- 52 Week Low
- MCHX $1.11
- MNOV $1.12
- 52 Week High
- MCHX $2.15
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- MCHX 45.01
- MNOV 52.22
- Support Level
- MCHX $1.67
- MNOV $1.49
- Resistance Level
- MCHX $1.90
- MNOV $2.55
- Average True Range (ATR)
- MCHX 0.13
- MNOV 0.18
- MACD
- MCHX -0.00
- MNOV 0.03
- Stochastic Oscillator
- MCHX 33.33
- MNOV 36.84
About MCHX Marchex Inc. Class B
Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.